• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926016350
Device Problems Bent (1059); Break (1069); Difficult to Remove (1528)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/22/2016
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.(b)(4).
 
Event Description
It was reported that balloon removal difficulty, shaft break, stent damage and stent explantation occurred.The target lesion was located in the proximal left anterior descending artery (lad).After a 3.50x 6 synergy ii everolimus-eluting platinum chromium coronary stent system was deployed, removal of the stent delivery system (sds) was attempted.However, the sds balloon became stuck on the stent and would not come back.A great force was applied to remove the device, but the shaft was separated and broke in half.The physician was able to grab the shaft with a lot of force and removed the device from the patient, but the stent was explanted and still on the balloon and deformed.The procedure was completed using a new guide, a non-bsc guide extension catheter and a 3.5x22mm non-bsc stent.No patient complications were reported and the patient¿s status was fine.
 
Manufacturer Narrative
Device evaluated by mfr: synergy ii, us, mr, 3.5 x 16mm stent delivery system (sds) was returned.A visual examination found the stent to be severely damaged.Struts overlapping and bunched towards the distal end of the balloon.The balloon showed signs that positive pressure was applied.Crimp pillowing/markings were not evident on the entire length of the balloon - highly pronounced crimp pillowing/markings would suggest that the balloon did not receive any significant positive pressure.A visual and tactile examination found several hypotube kinks along full length of catheter.This type of damage is consistent with excessive force being applied to the delivery system.A visual and tactile examination found a break in the polymer extrusion proximal of the port exchange site.The port bond also showed sign of a neck down.The bi-component bond showed no signs of damage or strain.A visual examination found no tip damage.No other issues were identified during the product analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause is operational context as device performance was limited due to anatomical procedural factors.(b)(4).
 
Event Description
It was reported that balloon removal difficulty, shaft break, stent damage and stent explantation occurred.The target lesion was located in the proximal left anterior descending artery (lad).After a 3.50x 6 synergy ii everolimus-eluting platinum chromium coronary stent system was deployed, removal of the stent delivery system (sds) was attempted.However, the sds balloon became stuck on the stent and would not come back.A great force was applied to remove the device, but the shaft was separated and broke in half.The physician was able to grab the shaft with a lot of force and removed the device from the patient, but the stent was explanted and still on the balloon and deformed.The procedure was completed using a new guide, a non-bsc guide extension catheter and a 3.5x22mm non-bsc stent.No patient complications were reported and the patient¿s status was fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Type of Device
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6187001
MDR Text Key62758042
Report Number2134265-2016-11592
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729840121
UDI-Public(01)08714729840121(17)20170407(10)19134491
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/28/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/07/2017
Device Model NumberH7493926016350
Device Catalogue Number39260-1635
Device Lot Number19134491
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/06/2016
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/28/2016
Initial Date FDA Received12/19/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/08/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/22/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-